Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Zou

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Japanese Journal of Cancer Research : Gann|November 1, 1993
Suppression of anti-tumor CD4+ T cell responsiveness in the tumor-bearing state and its recovery in in vitro culture free of tumor burdenT Nagata, J P Zou, N Yamamoto, et al.
International Journal of Cancer|September 25, 1997
Distamycin-A derivatives potentiate tumor-necrosis-factor activity via the modulation of tyrosine phosphorylationJ P Zou, I Nathan, A Dvilansky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1992
Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activityJ P Zou, J Shimizu, K Ikegame, et al.
Transplantation Proceedings|December 21, 2002
Study of the effect of indoleamine 2,3-dioxygenase on murine mixed lymphocyte reactions and skin allograft rejectionK Sakurai, J-P Zou, N I Torres, et al.
International Immunology|May 23, 2001
Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant responseJ Zhu, G M Shearer, F M Marincola, et al.
International Immunology|September 2, 1998
B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing stateR Wijesuriya, S Maruo, J P Zou, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1993
Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell functionX F Li, H Takiuchi, J P Zou, et al.
Cancer Research|October 27, 1997
Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stagesY F Yang, J P Zou, J Mu, et al.
Cancer Research|October 1, 1995
Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodesJ Mu, J P Zou, N Yamamoto, et al.
Journal of Clinical Immunology|January 29, 2002
IFN-alpha acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4+ and CD8+ T cellsY F Yang, M Tomura, M Iwasaki, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Japanese Journal of Cancer Research : Gann|November 1, 1993
Suppression of anti-tumor CD4+ T cell responsiveness in the tumor-bearing state and its recovery in in vitro culture free of tumor burdenT Nagata, J P Zou, N Yamamoto, et al.
International Journal of Cancer|September 25, 1997
Distamycin-A derivatives potentiate tumor-necrosis-factor activity via the modulation of tyrosine phosphorylationJ P Zou, I Nathan, A Dvilansky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1992
Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activityJ P Zou, J Shimizu, K Ikegame, et al.
Transplantation Proceedings|December 21, 2002
Study of the effect of indoleamine 2,3-dioxygenase on murine mixed lymphocyte reactions and skin allograft rejectionK Sakurai, J-P Zou, N I Torres, et al.
International Immunology|May 23, 2001
Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant responseJ Zhu, G M Shearer, F M Marincola, et al.
International Immunology|September 2, 1998
B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing stateR Wijesuriya, S Maruo, J P Zou, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1993
Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell functionX F Li, H Takiuchi, J P Zou, et al.
Cancer Research|October 27, 1997
Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stagesY F Yang, J P Zou, J Mu, et al.
Cancer Research|October 1, 1995
Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodesJ Mu, J P Zou, N Yamamoto, et al.
Journal of Clinical Immunology|January 29, 2002
IFN-alpha acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4+ and CD8+ T cellsY F Yang, M Tomura, M Iwasaki, et al.
Pageof 3